MXPA03010373A - Naphtothiazine positive allosteric ampa receptor modulators (paarm). - Google Patents
Naphtothiazine positive allosteric ampa receptor modulators (paarm).Info
- Publication number
- MXPA03010373A MXPA03010373A MXPA03010373A MXPA03010373A MXPA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A MX PA03010373 A MXPA03010373 A MX PA03010373A
- Authority
- MX
- Mexico
- Prior art keywords
- receptor modulators
- paarm
- naphtothiazine
- positive allosteric
- ampa receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
La presente invencion es concerniente con nuevos moduladores del receptor de AMP alostericos positivos de formula general (I), en donde R1, R2, R3, R4 y R5 pueden tener los significados dados en la especificacion y reivindicaciones, procesos para prepararlos y el uso de los mismos como composiciones farmaceuticas.The present invention is related to new positive allosteric AMP receptor modulators of general formula (I), wherein R1, R2, R3, R4 and R5 can have the meanings given in the specification and claims, processes for preparing them and the use of the same as pharmaceutical compositions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10123952A DE10123952A1 (en) | 2001-05-17 | 2001-05-17 | New naphtho-1,2-thiazine compounds, useful as neuroprotectants for treating e.g. epilepsy or Alzheimer's disease, are allosteric modulators of AMPA receptors |
| PCT/EP2002/005338 WO2002100411A1 (en) | 2001-05-17 | 2002-05-15 | Naphtothiazine positive allosteric ampa receptor modulators (paarm) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010373A true MXPA03010373A (en) | 2004-03-16 |
Family
ID=7685080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010373A MXPA03010373A (en) | 2001-05-17 | 2002-05-15 | Naphtothiazine positive allosteric ampa receptor modulators (paarm). |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1404340A1 (en) |
| JP (1) | JP2004529980A (en) |
| KR (1) | KR20040007572A (en) |
| CN (1) | CN1533278A (en) |
| AR (1) | AR036332A1 (en) |
| BG (1) | BG108324A (en) |
| BR (1) | BR0209796A (en) |
| CA (1) | CA2449189A1 (en) |
| CO (1) | CO5550460A2 (en) |
| CZ (1) | CZ20033112A3 (en) |
| DE (1) | DE10123952A1 (en) |
| EA (1) | EA006608B1 (en) |
| EC (1) | ECSP034852A (en) |
| EE (1) | EE200300566A (en) |
| HR (1) | HRP20030933A2 (en) |
| HU (1) | HUP0401273A3 (en) |
| IL (1) | IL158642A0 (en) |
| MX (1) | MXPA03010373A (en) |
| NO (1) | NO20035088D0 (en) |
| NZ (1) | NZ530154A (en) |
| PL (1) | PL364053A1 (en) |
| SK (1) | SK14222003A3 (en) |
| UY (1) | UY27290A1 (en) |
| WO (1) | WO2002100411A1 (en) |
| YU (1) | YU90403A (en) |
| ZA (1) | ZA200308466B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2061471A4 (en) * | 2006-08-31 | 2012-02-01 | Univ Alberta | METHOD OF INHIBITING RESPIRATORY DEPRESSION IN WHICH AMPA RECEPTORS ARE POSITIVE ALLOSTERIC MODULATORS |
| CN111518058B (en) * | 2020-05-29 | 2021-03-09 | 四川大学华西医院 | Oxathiazine compound and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998012185A1 (en) * | 1996-09-17 | 1998-03-26 | The Regents Of The University Of California | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
| JP2002518498A (en) * | 1998-06-25 | 2002-06-25 | メルク エンド カムパニー インコーポレーテッド | Naphtho [1,8-de] thiazin-2-ylmethylcarbapenem antibacterial |
| DE10004572A1 (en) * | 2000-02-02 | 2001-08-09 | Boehringer Ingelheim Pharma | New positive allosteric AMPA receptor modulators (PAARM), processes for their production and their use as medicines |
-
2001
- 2001-05-17 DE DE10123952A patent/DE10123952A1/en not_active Withdrawn
-
2002
- 2002-05-15 CN CNA028100832A patent/CN1533278A/en active Pending
- 2002-05-15 CA CA002449189A patent/CA2449189A1/en not_active Abandoned
- 2002-05-15 WO PCT/EP2002/005338 patent/WO2002100411A1/en not_active Ceased
- 2002-05-15 EE EEP200300566A patent/EE200300566A/en unknown
- 2002-05-15 IL IL15864202A patent/IL158642A0/en unknown
- 2002-05-15 HR HR20030933A patent/HRP20030933A2/en not_active Application Discontinuation
- 2002-05-15 NZ NZ530154A patent/NZ530154A/en unknown
- 2002-05-15 PL PL02364053A patent/PL364053A1/en not_active Application Discontinuation
- 2002-05-15 EA EA200301167A patent/EA006608B1/en not_active IP Right Cessation
- 2002-05-15 JP JP2003503232A patent/JP2004529980A/en not_active Abandoned
- 2002-05-15 HU HU0401273A patent/HUP0401273A3/en unknown
- 2002-05-15 BR BR0209796-6A patent/BR0209796A/en not_active IP Right Cessation
- 2002-05-15 UY UY27290A patent/UY27290A1/en not_active Application Discontinuation
- 2002-05-15 KR KR10-2003-7014965A patent/KR20040007572A/en not_active Withdrawn
- 2002-05-15 MX MXPA03010373A patent/MXPA03010373A/en unknown
- 2002-05-15 CZ CZ20033112A patent/CZ20033112A3/en unknown
- 2002-05-15 EP EP02750931A patent/EP1404340A1/en not_active Withdrawn
- 2002-05-15 SK SK1422-2003A patent/SK14222003A3/en unknown
- 2002-05-15 YU YU90403A patent/YU90403A/en unknown
- 2002-05-17 AR ARP020101827A patent/AR036332A1/en unknown
-
2003
- 2003-10-30 ZA ZA200308466A patent/ZA200308466B/en unknown
- 2003-11-07 BG BG108324A patent/BG108324A/en unknown
- 2003-11-14 NO NO20035088A patent/NO20035088D0/en not_active Application Discontinuation
- 2003-11-17 EC EC2003004852A patent/ECSP034852A/en unknown
- 2003-12-01 CO CO03105591A patent/CO5550460A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG108324A (en) | 2004-12-30 |
| CA2449189A1 (en) | 2002-12-19 |
| UY27290A1 (en) | 2002-12-31 |
| JP2004529980A (en) | 2004-09-30 |
| NO20035088L (en) | 2003-11-14 |
| HUP0401273A3 (en) | 2006-11-28 |
| EA006608B1 (en) | 2006-02-24 |
| IL158642A0 (en) | 2004-05-12 |
| YU90403A (en) | 2006-05-25 |
| NO20035088D0 (en) | 2003-11-14 |
| EE200300566A (en) | 2004-02-16 |
| EA200301167A1 (en) | 2004-06-24 |
| EP1404340A1 (en) | 2004-04-07 |
| ECSP034852A (en) | 2003-12-24 |
| WO2002100411A1 (en) | 2002-12-19 |
| KR20040007572A (en) | 2004-01-24 |
| AR036332A1 (en) | 2004-09-01 |
| HUP0401273A2 (en) | 2004-10-28 |
| NZ530154A (en) | 2005-09-30 |
| DE10123952A1 (en) | 2002-11-21 |
| HRP20030933A2 (en) | 2004-04-30 |
| ZA200308466B (en) | 2004-05-24 |
| PL364053A1 (en) | 2004-12-13 |
| CZ20033112A3 (en) | 2004-03-17 |
| BR0209796A (en) | 2004-06-01 |
| CO5550460A2 (en) | 2005-08-31 |
| SK14222003A3 (en) | 2004-05-04 |
| CN1533278A (en) | 2004-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY31524A1 (en) | NEW COMPOUNDS 010 | |
| UY29886A1 (en) | NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS | |
| PA8593001A1 (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| SE0202133D0 (en) | Novel compounds | |
| UY30808A1 (en) | BENZOTIAZOLONAS DERIVATIVES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| BRPI0408347A (en) | pyrimidine derivatives | |
| UY27109A1 (en) | DERIVATIVES OF QUINAZOLONA AS ANTAGONISTS OF ADRENERGIC RECEPTORS ALFA-1A / B | |
| CL2008002132A1 (en) | Compounds derived from sulfonamides, modulators of trpm8; pharmaceutical compositions comprising said compounds; and use of said compounds in the treatment of neuropathic pain, inflammatory pain, anxiety, depression, inflammatory hyperalgesia, among others. | |
| AR057325A1 (en) | SYNTHESIS OF (S) -N-METHYLNTREXONE, PHARMACEUTICAL COMPOSITIONS AND USES | |
| ECSP045229A (en) | PIRIDINONES REPLACED AS MODULATORS OF THE P38 MAP QUINASA | |
| ATE433447T1 (en) | PYRIMIIDINE COMPOUNDS | |
| ECSP066667A (en) | SPIROCICLIC CYCLHEXAN DERIVATIVES | |
| UY31481A1 (en) | NEW PIRIMIDINE DERIVATIVES, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| BRPI0410025A (en) | amino-propanol derivatives as sphingosine-1-phosphate receptor modulator | |
| BRPI0411528A (en) | use of isomalt as prebiotic | |
| UY29795A1 (en) | ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| UY30206A1 (en) | DIAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| HRP20070076A2 (en) | Pyrimidine derivatives | |
| SV2008002986A (en) | INDOL SULFONAMIDE MODULATORS OF PROGESTERONE RECEPTORS REF. X-17207 | |
| ECSP055671A (en) | NEW ESPIROCONDENSED QUINAZOLINONES AND ITS USE AS PHOSPHODESTERESA INHIBITORS | |
| UY27851A1 (en) | DIFENILAZETIDINONAS REPLACED IN RING, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE. | |
| SV2004001548A (en) | DIFENILAZETIDINONAS REPLACED IN ACID GROUP, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE | |
| CR9652A (en) | MODULATORS OF ALQUILQUINOLINA AND ALQUILQUINAZOLINA CINASA | |
| UY28694A1 (en) | NEW COMPOUNDS | |
| ECSP088603A (en) | NEW N- (FLUOR-PIRAZINIL) -PENYLSULPHONAMIDES AS MODULATORS OF THE CCR4 CHEMIOQUINE RECEPTOR |